EA
BSX icon

Euclid Advisors’s Boston Scientific BSX Stock Holding History

Euclid Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-97,062
Closed -$2.27M – 84
2016
Q2 		$2.27M Buy
97,062
+12,050
+14% +$261K 0.1% 261
2016
Q1 		$1.6M Sell
85,012
-40,304
-32% -$708K 0.06% 298
2015
Q4 		$2.31M Buy
+125,316
New +$2.25M 0.07% 261
2015
Q3 		– Sell
-58,550
Closed -$1.04M – 254
2015
Q2 		$1.04M Sell
58,550
-432,870
-88% -$7.74M 0.02% 348
2015
Q1 		$8.72M Buy
+491,420
New +$7.77M 0.16% 149
2014
Q4 		– Sell
-677,680
Closed -$8M – 386
2014
Q3 		$8M Buy
677,680
+36,170
+6% +$455K 0.06% 292
2014
Q2 		$8.19M Sell
641,510
-94,539
-13% -$1.23M 0.06% 299
2014
Q1 		$9.95M Buy
736,049
+192,860
+36% +$2.53M 0.08% 237
2013
Q4 		$6.53M Sell
543,189
-27,910
-5% -$330K 0.05% 316
2013
Q3 		$6.71M Buy
571,099
+116,334
+26% +$1.26M 0.07% 265
2013
Q2 		$4.22M Buy
+454,765
New +$3.86M 0.05% 327

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Euclid Advisors's BSX Position: Q3 2016 in Review

Euclid Advisors sold out of Boston Scientific (BSX) in Q3 2016, closing a stake of 97,062 shares — an estimated $2.27M sold.

Euclid Advisors first reported a position in BSX in Q2 2013 and held it in 11 quarters. The position peaked at $9.95M in Q1 2014. 566 funds tracked by Wall St. Rank hold BSX as of Q3 2016.

  • Euclid Advisors reported no remaining Boston Scientific position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 97,062 Boston Scientific shares in Q3 2016, an estimated $2.27M.
  • Euclid Advisors first reported a position in Boston Scientific in Q2 2013 and held it in 11 quarters.
  • Euclid Advisors's Boston Scientific position peaked at $9.95M in Q1 2014.
  • 566 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.